Palvella Therapeutics (PVLA) announced it has been added to the broad-market Russell 3000 Index and the Russell 2000 Index, effective after the U.S. market opens on June 30, as part of the 2025 Russell indexes reconstitution.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.